Solubility enhancement of poorly soluble drugs

Solubility enhancement of poorly soluble drugs

Products
Solubility enhancement of poorly soluble drugs
Solubility enhancement of poorly soluble drugs

Information

Amorphous Solid Dispersions via fluidbed granulation to achieve free flowing and direct compressible granules of the API in an amorphous form. This solution offers an optimized downstream process in comparision to the standard spray drying process. Glatt Pharmaceutical Services supports the formulation and process development as well as the GMP manufacturing both for clininal and commercial. We service our customers in our sites in USA (Ramsey) and Germany (Binzen)
Distribution Areas
North America (USA, Canada)Middle East Region (e.g. UAE)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
GermanyUnited States
All categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Services
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)
Glatt Pharmaceutical Services GmbH & Co. KGlatt Pharmaceutical Services develops and produces solid pharmaceutical dosage forms. Our focus lies on multiparticulate systems such as pellets, micropellets and granules. Whether you are looking for optimal bioavailablity or taste masking, improved solubility or stabilization of the dosage form, we have the right solution for every challenge. Glatt Pharmaceutical Services brings together fundamentals, experience and innovative technology expertise. With our comprehensive services, we support you from product idea to market launch.

Log in

See all the content and easy-to-use features by logging in or registering!